west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "补体" 21 results
  • 炎症在癫痫发病机制中的研究进展

    炎症在癫痫发病机制中的作用越来越受到关注,成为近年来的研究热点。文章将对血脑屏障(Blood brain barrier,BBB)、高迁移率族蛋白 1(High mobility group box-1 protein,HMGB1)、白介素-1(Interleukin,IL-1)、肿瘤坏死因子-α(Tumor necrosis factor-α,TNF-α)、趋化因子(Chemotactic factors)及补体因子(Complement factors)在癫痫发病机制中的作用进行总结,分析并概述干预这些炎症通路作为癫痫辅助治疗的前景,为癫痫致病机制和临床诊治研究提供一定帮助。

    Release date:2018-01-20 10:51 Export PDF Favorites Scan
  • CLINICAL STUDY ON SERUM COMPLEMENT-3 AND PLASMA FIBRONECTIN OF PATIENTS WITH OBSTRUCTIVE JAUNDICE PRE- AND POST-OPERATION

    Thirty patients with obstructive jaundice were investigated for serum complement-3 (C3) and plasma fibronectin (FN).The levels of C3 and FN of the juandiced patients were higher than that of thirty patients without obstructive jaundice (P<0.01). As compared to pre-operation, the level of C3 of the jaundiced patients decreased obviously within two weeks after operation(P<0.01), and recovered in the third week after operation. The level of FN of the juandice patients decreased evidently within one week(P<0.01), and recovered in the second week after operation. However, the levels of C3 and FN of the patients without obstructive jaundice changed slightly after operation (P<0.05). The high levels of C3 and FN of jaundiced patients may be relative to the latent infection. Consumption and immune imparing may be the reasons of C3 and FN to decrease.

    Release date:2016-08-29 03:44 Export PDF Favorites Scan
  • The Role of theComplement Receptor 1 and 3 on Neutrophils in Distinguishing Bacterial Infection in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

    Objective To study the role of the complement receptor 1 and 3 ( CR1 and CR3) on neutrophils in distinguishing bacterial infection in patients with acute exacerbation of chronic obstructive pulmonary disease ( AECOPD) . Methods 40 patients with AECOPD were divided into two groups according to the detection of bacteria in subairway. 20 patients with stable COPD and 20 healthy subjects with no history of smoking were also included. According to Anthonisen criteria, 40 AECOPD patients weredivided into type Ⅰ( 11 cases) , type Ⅱ ( 12 cases) , and type Ⅲ( 17 cases) . The levels of CR1 and CR3 in blood were measured by flow cytometry. Results In AECOPD patients, 25 cases were detected bacteria,and 15 cases were not detected bacteria. The level of CR1 and CR3 were highest in the bacterial infection group than other groups, and highest in type Ⅰ AECOPD patients than other types. ROC analysis showed that CR1 and CR3 had good diagnostic value in bacterial infection in AECOPD, with optimal cutoff values of 11 and 52, respectively. Conclusion CR1 and CR3 may be good index of distinguishing bacterial infection in AECOPD.

    Release date:2016-08-30 11:53 Export PDF Favorites Scan
  • 补体在渗出型老年性黄斑变性中的作用研究进展

    补体系统是机体免疫系统的重要组成部分,广泛参与机体抗微生物防御反应,清除凋亡细胞和免疫复合物以及维持组织稳态,进行免疫调节。补体系统与老年性黄斑变性(AMD)发生也密切相关。在玻璃膜疣中,含有多种选择激活途径中的蛋白;补体成分基因变异也使AMD的发病风险大大增加。补体系统多种分子与AMD CNV形成关系密切,针对补体系统异常激活的治疗可能为渗出型AMD的治疗带来新的曙光。

    Release date:2016-09-02 05:26 Export PDF Favorites Scan
  • 补体因子H与老年性黄斑变性

    Release date:2016-09-02 05:48 Export PDF Favorites Scan
  • 补体系统在老年性黄斑变性发病机制中的作用

    补体系统是机体固有免疫的重要组成部分,包含分布于血浆中或细胞表面的40多种物质,可通过经典途径、凝集素途径或替代途径激活。补体系统通过炎症免疫、血管内皮生长因子表达上调、氧化应激等途径参与和影响老年性黄斑变性(AMD)的发生发展过程;其相关分子的基因多态性与AMD的易感性息息相关;靶向补体系统的治疗对AMD也有一定的疗效。补体系统与AMD相互关系的研究将有助于进一步阐明AMD的发病机制并为其治疗提供新的方向。

    Release date:2016-09-02 05:26 Export PDF Favorites Scan
  • The genetic predisposition of complement C5 gene polymorphisms in proliferative diabetic retinopathy in Chongqing Han population

    Objective To observe the genetic predisposition of complement C5 gene polymorphisms in proliferative diabetic retinopathy (PDR) in Chongqing Han population. Methods 400 type 2 diabetes (T2D) patients (case group) and 600 age- and sex-matched healthy controls (control group) were enrolled in this study. There were 8 PDR patients in case group. All the subjects were Han ethnic people. The immune-related representative SNP locus of C5 gene including rs2269067, rs7040033, rs7027797 were screened by linkage disequilibrium analysis. Locus rs1017119 was selected by TagSNP and was around the above three loci. Subjects′ peripheral venous blood was collected and DNA was extracted. Genotyping was examined by PCR-restriction fragment length polymorphism method. The level of C5 plasma protein was measured by enzyme-linked immunoabsorbent assay. Results The frequency of GG genotype of rs2269067 was significantly increased in PDR patients in cases group compared with controls (Pc=3.4×10-5, OR=1.87, 95%CI=1.43 - 2.44;P=3.1×10-6). There was no differences in frequency of G, CC and CG genotype of rs2269067 between two groups (P=1.4×10-4, 1.000, 1.0×10-6). There were no differences in frequency of G, CC, CG, GG genotype of rs7040033, rs1017119, and rs7027797 between two groups (P > 0.05). The production of C5 plasma protein was significantly increased in case group as compare with control group (P=0.0004). An increased production of C5 plasma protein was observed in rs2269067 GG genotype cases compared to CG or CC cases (P=0.003, 0.001). Conclusion C5 rs2269067 GG genotype may be associated with the PDR of T2D in Chongqing Han population.

    Release date: Export PDF Favorites Scan
  • 肝叶切除后胆汁免疫球蛋白和补体变化的临床意义

    Release date:2016-08-29 09:20 Export PDF Favorites Scan
  • 阵发性睡眠性血红蛋白尿症的靶向治疗

    阵发性睡眠性血红蛋白尿症(PNH)是一种罕见的造血干细胞克隆性的溶血性疾病,目前治疗困难。重组人源型抗补体蛋白C5单克隆抗体(eculizumab)的出现及临床应用开启了PNH靶向治疗的新篇章。eculizumab通过与补体C5结合,防止C5裂解形成C5b及膜攻击复合物,减少溶血,降低输血需求,提高患者生活质量。2007年,eculizumab分别被美国食品和药物管理局、欧盟委员会通过用于治疗PNH血管内溶血。现对PNH患者使用eculizumab靶向治疗作一综述。

    Release date: Export PDF Favorites Scan
  • Study on the relationship between immune state and disease progression or disease severity of patients infected with hepatitis B virus

    Objective To explore the relationship between immune state and disease progression or severity of patients with hepatitis B virus (HBV). Methods A total of 332 patients infected with HBV diagnosed and treated from January 2012 to December 2013 were divided into acute hepatitis B (AHB) group (n=25), chronic hepatitis B (CHB) group (n=237) and cirrhosis group (n=70) according to disease progression. Moreover, CHB group was divided into mild (n=24), moderate (n=103), serious (n=72) and severe group (liver failure group,n=38) according to disease severity, while cirrhosis group was divided into hepatocellular carcinoma (HCC) group (n=13) and non-HCC group (n=57). The immune indexes including immunoglobulin (Ig), complement (C) and T-lymphocyte subsets were tested and compared. Results The immune indexes were not significantly different between AHB group and CHB group (P>0.05). Compared with AHB group and CHB group, cirrhosis group had higher levels of IgG and IgA, and lower levels of CD3+, CD4+ and CD8+ T cells count (P<0.05). Compared with non-HCC group, HCC group had more male patients without antiviral therapy, who had higher levels of C3 and C4 (P<0.05). As disease progressed, the levels of alanine fcell couaminotransferase, aspartate aminotransferase, total cholesterol, Fibroscan index, IgG, and IgA of CHB patients all gradually increased, while the levels of C3 and C4 and the counts of CD3+ and CD4+ T cells gradually declined. Conclusions The immune state of patients infected with HBV has a certain relationship with disease progression or severity, and immunoglobulin, complement and T cells count can partly reflect the severity of the disease. Cirrhosis patients accompanied with high levels of C3 and C4 should pay high attention to antiviral therapy and be vigilant on HCC.

    Release date:2017-01-18 08:50 Export PDF Favorites Scan
3 pages Previous 1 2 3 Next

Format

Content